Indeed, the tumor sphere formation from both patient derived L2G+ TN1 and mouse 4T1 breast cancer cells was largely impaired by USP22 CRISPR deletion, which was further confirmed by an in vitro extremely limiting dilution assay (Fig. 1E–G, s1F-H). The gene discussed is USP22; the disease is breast carcinoma.